Real World Study of Linperlisib for Lymphoma Treatment

Clinical trial NCT05863871 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05863871
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Focus on the Lymphoma Including B/T-cell Lymphoma

Start date: 2023-05-01
Primary completion: 2027-06-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.